Yahoo Finance

Dividend Yield: 6.8%

Consun Pharmaceutical Group's dividend yield of 6.82% is below the top 25% in Hong Kong, with a history of volatility and unreliability over the past decade despite some growth. Dividends are well-covered by earnings and cash flows, with payout ratios at 52.3% and 54%. Trading at a significant discount to fair value indicates potential for capital gains; however, recent executive changes may impact stability. The ongoing CKD drug trial could influence future performance.

• Take a closer look at Consun Pharmaceutical Group's potential here in our dividend report.

• In light of our recent valuation report, it seems possible that Consun Pharmaceutical Group is trading behind its estimated value.

GakkyushaLtd

Simply Wall St Dividend Rating: ★★★★★★

Overview: Gakkyusha Ltd (TSE:9769) operates cram schools providing entrance exam guidance for junior high, high school, and university students in Japan and internationally, with a market cap of ¥24.64 billion.

Operations: Gakkyusha Ltd (TSE:9769) generates revenue primarily from its management of educational institutions that prepare students for entrance exams at various academic levels both domestically and abroad.

Dividend Yield: 4%

Gakkyusha Ltd. offers a compelling dividend profile with a yield of 3.97%, placing it in the top quartile of Japanese dividend payers. The company's dividends have been stable and growing over the past decade, supported by earnings and cash flows, with payout ratios at 51.2% and 50.8%. Additionally, Gakkyusha trades at a notable discount to its estimated fair value, suggesting potential for capital appreciation alongside reliable income generation from dividends.

• Unlock comprehensive insights into our analysis of GakkyushaLtd stock in this dividend report.

• Our expertly prepared valuation report GakkyushaLtd implies its share price may be lower than expected.

Next Steps

• Click through to start exploring the rest of the 1128 Top Asian Dividend Stocks now.

• Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.

• Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Interested In Other Possibilities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include KOSE:A234080 SEHK:1681 and TSE:9769.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com